Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies

Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies

Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present data on the use of rituximab in the treatment of fol...

Full description

Bibliographic Details
Main Authors: Martina Bogeljić Patekar, Karla Mišura Jakubac, Inga Mandac Rogulj, Delfa Radić-Krišto, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić, Vibor Milunović
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2017-01-01
Series:Acta Clinica Croatica
Subjects:
Rituximab
Lymphoma, non-Hodgkin – therapy
Lymphoma, follicular
Maintenance chemotherapy
Treatment outcome
Online Access:http://hrcak.srce.hr/file/271979

Internet

http://hrcak.srce.hr/file/271979

Similar Items